IngenoVax LLC logo

IngenoVax LLC

IngenoVax is developing novel immunotherapies to treat cancers using its patented Microbial Mimetics vaccine platform.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.ingenovax.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
20147 SW Monson St, OR 97006
Beaverton
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/ingenobio” connections=”true” suffix=””]